Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -19.33 is 23% below its 5-year average of -15.69, around the middle of its 5-year range (-33.00–-6.36).
53.96% below its 12-month average of -12.55.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -4.08.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 12 comparable quarters.
EARNINGS PER SHARE (EPS)
-19.33
EARNINGS PER SHARE (EPS) AVG TTM
-12.55
EARNINGS PER SHARE (EPS) AVG 3Y
-11.71
EARNINGS PER SHARE (EPS) AVG 5Y
-15.69
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-53.96%
CURRENT VS 3Y AVG
-65.00%
CURRENT VS 5Y AVG
-23.24%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Jupiter Neurosciences, Inc.
Market Cap
$1.18M
Earnings Per Share (EPS)
-19.33
TTM Avg
-12.55
3Y Avg
-11.71
5Y Avg
-15.69
Market Cap
$1.17M
Earnings Per Share (EPS)
N/A
TTM Avg
-76.17
3Y Avg
-936.34
5Y Avg
-837.30
Market Cap
$1.10M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.03
3Y Avg
0.05
5Y Avg
0.05
Market Cap
$1.07M
Earnings Per Share (EPS)
-89.20
TTM Avg
-39.24
3Y Avg
-1704.73
5Y Avg
-1696.36
Market Cap
$1.31M
Earnings Per Share (EPS)
-158.78
TTM Avg
-3127.89
3Y Avg
-13218.44
5Y Avg
-15729.46
Market Cap
$1.03M
Earnings Per Share (EPS)
-8.02
TTM Avg
-25.27
3Y Avg
-9.38
5Y Avg
-7.51
Market Cap
$1.40M
Earnings Per Share (EPS)
-74.28
TTM Avg
-29.19
3Y Avg
-19.57
5Y Avg
-19.24
Market Cap
$1.41M
Earnings Per Share (EPS)
-0.71
TTM Avg
-0.44
3Y Avg
-0.57
5Y Avg
-0.58
Market Cap
$1.43M
Earnings Per Share (EPS)
N/A
TTM Avg
-14.23
3Y Avg
-10.02
5Y Avg
-9.01
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Jupiter Neurosciences, Inc. (JUNS) | $1.18M | -19.33 | -12.55 | -11.71 | -15.69 |
| IM Cannabis Corp. (IMCC)vs › | $1.17M | N/A | -76.17 | -936.34 | -837.30 |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.10M | N/A | -0.03 | 0.05 | 0.05 |
| Clearmind Medicine Inc. (CMND)vs › | $1.07M | -89.20 | -39.24 | -1704.73 | -1696.36 |
| Genprex, Inc. (GNPX)vs › | $1.31M | -158.78 | -3127.89 | -13218.44 | -15729.46 |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.03M | -8.02 | -25.27 | -9.38 | -7.51 |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.40M | -74.28 | -29.19 | -19.57 | -19.24 |
| NEXGEL, Inc. (NXGL)vs › | $1.41M | -0.71 | -0.44 | -0.57 | -0.58 |
| NewcelX Ltd. (NCEL)vs › | $1.43M | N/A | -14.23 | -10.02 | -9.01 |
| PMGC Holdings Inc. (ELAB)vs › | $1.45M | -1815.30 | -34855.30 | -136953.83 | -91453.81 |
Trailing EPS (TTM)
$-19.33
Forward EPS (Est.)
$4.50
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -18.75 |
| 2024-12-31 | -6.36 |
| 2023-12-31 | -10.50 |
| 2022-12-31 | -11.25 |
| 2021-12-31 | -33.00 |
| 2020-12-31 | -14.25 |
| 2019-12-31 | -26.25 |
